Royal Bank of Canada’s Albireo Pharma, Inc. Common Stock ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,397
| Closed | -$51K | – | 7201 |
|
|
2022
Q4 | $51K | Buy |
2,397
+1,916
| +398% | +$40.8K | ﹤0.01% | 5405 |
|
|
2022
Q3 | $10K | Buy |
481
+351
| +270% | +$7.3K | ﹤0.01% | 5953 |
|
|
2022
Q2 | $3K | Sell |
130
-906
| -87% | -$20.9K | ﹤0.01% | 6428 |
|
|
2022
Q1 | $31K | Sell |
1,036
-2,714
| -72% | -$81.2K | ﹤0.01% | 5887 |
|
|
2021
Q4 | $87K | Buy |
3,750
+2,305
| +160% | +$53.5K | ﹤0.01% | 5510 |
|
|
2021
Q3 | $45K | Buy |
1,445
+190
| +15% | +$5.92K | ﹤0.01% | 5710 |
|
|
2021
Q2 | $45K | Buy |
1,255
+103
| +9% | +$3.69K | ﹤0.01% | 5621 |
|
|
2021
Q1 | $41K | Buy |
1,152
+90
| +8% | +$3.2K | ﹤0.01% | 5519 |
|
|
2020
Q4 | $40K | Buy |
1,062
+555
| +109% | +$20.9K | ﹤0.01% | 5207 |
|
|
2020
Q3 | $17K | Sell |
507
-122
| -19% | -$4.09K | ﹤0.01% | 5275 |
|
|
2020
Q2 | $17K | Buy |
629
+467
| +288% | +$12.6K | ﹤0.01% | 5189 |
|
|
2020
Q1 | $3K | Sell |
162
-510
| -76% | -$9.44K | ﹤0.01% | 5730 |
|
|
2019
Q4 | $18K | Buy |
672
+572
| +572% | +$15.3K | ﹤0.01% | 5313 |
|
|
2019
Q3 | $2K | Hold |
100
| – | – | ﹤0.01% | 5665 |
|
|
2019
Q2 | $3K | Hold |
100
| – | – | ﹤0.01% | 5566 |
|
|
2019
Q1 | $3K | Hold |
100
| – | – | ﹤0.01% | 5471 |
|
|
2018
Q4 | $2K | Sell |
100
-173
| -63% | -$3.46K | ﹤0.01% | 5588 |
|
|
2018
Q3 | $9K | Buy |
273
+96
| +54% | +$3.17K | ﹤0.01% | 5437 |
|
|
2018
Q2 | $7K | Buy |
177
+77
| +77% | +$3.05K | ﹤0.01% | 5374 |
|
|
2018
Q1 | $3K | Buy |
100
+90
| +900% | +$2.7K | ﹤0.01% | 5458 |
|
|
2017
Q4 | $0 | Buy |
+10
| New | – | ﹤0.01% | 6149 |
|